No GLP-1 drug is approved for cognitive indications
13 In the 1980s, L-carnitine was marketed as a commercial product abroad and was included in the United States Pharmacopeia, 22nd edition
Even within each company, coverage varies and is determined based on two key factors: Your Plan Type large employer / small employer / Medicare / Medicaid / Federal BCBS State Guidelines this determines foundational requirements for the above, but does not always apply Coverage Varies Widely BCBS coverage differences are driven by who controls your benefits (employer vs insurer), how the plan is funded (fully insured vs self-funded), and your medical indication
Semaglutide by Vitastir has truly transformed my life
Liraglutide, a glucagon-like peptide-1 receptor agonist, suppresses osteoclastogenesis through the inhibition of NF-B and MAPK pathways via GLP-1R
It's also a cofactor for several antioxidant enzymes and is needed to regenerate vitamins C and E to use again in the antioxidant pathways